Leukotrap Wb System
Product Images NDC 53157-136

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Leukotrap Wb System (NDC 53157-136). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Haemonetics Manufacturing, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Envelope Label (Image 01)

Envelope Label (Image 01)
Haemonetics' WB 500 ml Quad CPDA-1 Leukotrap® WB System is used for the collection of blood and preparation of red blood cells and plasma with pre-storage leukocyte reduction. The system consists of a collection bag with 70 ml of CPDA-1 solution and four empty bags. Each 70 ml of CPDA-1 solution contains 2.23 g dextrose, 1.84 g sodium citrate, 0.229 g citric acid, 0.155 g monobasic sodium phosphate, and 0.019 g adenine. This is a sterile, nonpyrogenic, and steam-sterilized fluid path Rx-only product. For storage guidance, unused bags in open pouches may be kept for 30 days by folding and securing the open end of the pouch to avoid possible moisture loss. The Haemonetics Corporation manufactures this product for the medical industry. Unfortunately, there are no specific WI-FI available.*
FDA Label Image

Collection Bag Label (Image 02)

Collection Bag Label (Image 02)
This is a description of a blood collection kit, containing 500ml of CPDA-1 whole blood, which is mixed with 70 CPDA-1 anticoagulant solution and needs to be stored at 16 degrees Celsius. The kit is intended for volunteer donors, and proper identification of the recipient is essential. The kit uses an anticoagulant containing citrate, phosphate, dextrose, and 65 adenine solution, and includes collection/processing instructions and label hours. The kit is manufactured by Hacmaretios Corporation in the USA, but further information regarding indications and calculations should be sought from a circular or other documentation.*
FDA Label Image

Plasma Bag Label (Image 03)

Plasma Bag Label (Image 03)
This appears to be labeling information for a plasma bag. The bag has been labeled "PLASMABAG" and is specified as "LEUKOCYTES REDUCED." The label refers to a circular of information for indications and methods of use. The donor is identified as a "VOLUNTEER DONOR," and proper identification of the intended recipient is required. There is an expiration date listed, and a spot to affix a collection/processing label. The bag is associated with the Hemocare Corporation in Tacoma, Washington.*
FDA Label Image

Transfer Bag Label (Image 04)

Transfer Bag Label (Image 04)
This is a label from a unit of CPDA-1 red blood cells with leukocytes reduced collected from a volunteer donor on a specific date with a unique unit number. The circular of information is referenced for instructions related to infusion and notes that the product may transmit infectious agents. Proper identification of the intended recipient is advised. The expiration date is noted and storage instructions are given. The label includes manufacturing information for the Haemonetics Corporation.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.